Articles on weight-loss medicines: how GLP-1 drugs and similar treatments work, who they are intended for, the side effects to expect and what happens when treatment stops. These are prescription medicines that need medical supervision.
Ozempic is not approved for prediabetes; its US label covers type 2 diabetes. Semaglutide, the same molecule sold as Wegovy, is approved for weight…
On Ozempic (semaglutide), most dietitians suggest building each smaller meal around a lean protein, adding fiber-rich vegetables, fruit, beans or whole grains gradually, and…
Ozempic (semaglutide) is not approved for polycystic ovary syndrome; any use for PCOS is off-label. Small, short trials of GLP-1 medicines in women with…
Ozempic (semaglutide) does not appear to harm bone directly; randomized trials and pooled analyses of GLP-1 medicines show no clear rise in fractures. The…
On GLP-1 medicines such as semaglutide and tirzepatide, roughly 25 to 40 percent of the weight lost in trial body-composition substudies was lean mass,…
Ozempic constipation, nausea and sulfur burps share one root cause: the medicine slows how fast food leaves the stomach and moves through the gut.…
Hair loss on Ozempic or Mounjaro is usually telogen effluvium, a temporary shedding that begins two to four months after rapid weight loss or…
Drinking alcohol while taking Ozempic (semaglutide) is not prohibited by its prescribing information, but the combination can raise the risk of low blood sugar,…
Ozempic (semaglutide) carries a US boxed warning because it caused thyroid C-cell tumors in rats and mice; whether that applies to people is unknown.…
"Ozempic butt" is the informal name for a flatter, softer or looser-looking backside after substantial weight loss on GLP-1 medicines such as semaglutide or…
Ozempic (semaglutide) works by mimicking GLP-1, a gut hormone released after meals. It prompts the pancreas to release insulin only when blood sugar is…
Orforglipron is an investigational once-daily oral GLP-1 receptor agonist, a small-molecule pill rather than an injected peptide. In published phase 3 trials, adults with…
Tirzepatide and semaglutide are both weekly prescription medicines that mimic the gut hormone GLP-1 to reduce appetite and lower blood sugar; tirzepatide also activates…
The Wegovy pill and the Wegovy injection contain the same active drug, semaglutide, but the pill is taken daily, is absorbed in the stomach…
"Ozempic face" is an informal term for the hollow cheeks, sunken temples, deeper folds and looser jawline that can follow rapid weight loss on…
Mounjaro (tirzepatide) side effects are mostly digestive: nausea, diarrhea, constipation, vomiting and indigestion, reported by roughly one in four to one in three people…
Retatrutide is an investigational weekly injectable medicine that activates three gut-hormone receptors, GLP-1, GIP and glucagon, to reduce appetite and body weight.…
The most common Ozempic side effects are digestive: nausea, diarrhea, vomiting, constipation and stomach discomfort, affecting roughly one in five people in trials and…
Choose which cookies you allow. Essential cookies are always on because the site cannot work without them.
